Page last updated: 2024-08-23

bromocriptine and Cardiomyopathies, Primary

bromocriptine has been researched along with Cardiomyopathies, Primary in 50 studies

Research

Studies (50)

TimeframeStudies, this research(%)All Research%
pre-19901 (2.00)18.7374
1990's1 (2.00)18.2507
2000's9 (18.00)29.6817
2010's31 (62.00)24.3611
2020's8 (16.00)2.80

Authors

AuthorsStudies
Chaparro, S; Hernandez, GA; Ibrahim, M; Kittipibul, V; Mahabir, S; Saint Croix, GR; Trongtorsak, A1
Mujkanovic, J; Qayyum, AA1
Adamo, L; Al'Aref, SJ; Asnani, A; Chidambaram, V; Kumar, A; Lau, ES; Majella, MG; Mehta, JL; Ravi, R; Sharma, G; Sinha, S; Sivakumar, RK1
Bauersachs, J; Berliner, D; Erschow, S; Haebel, L; Hilfiker-Kleiner, D; Koenig, T; Mueller, JH; Pfeffer, TJ; Ricke-Hoch, M; Scherr, M; Talbot, SR; Yalman, KC; Zwadlo, C1
Bauersachs, J; Berliner, D; König, T; Pfeffer, TJ1
Abdullaev, TA; Kurbanov, RD; Mirzarakhimova, ST; Tsoy, IA1
Demkow, M; Dzielinska, Z; Kryczka, KE1
Akhyari, P; Hilfiker-Kleiner, D; Horn, P; Kelm, M; Saeed, D; Westenfeld, R1
Arrigo, M; Blet, A; Mebazaa, A1
Angermann, CE; Bauersachs, J; Berliner, D; Böhm, M; Ehlermann, P; Fischer, D; Franke, A; Haghikia, A; Hilfiker-Kleiner, D; Kindermann, I; Kühl, U; Michels, G; Pfister, R; Podewski, E; Schlitt, A; Schwab, J; Schwarzkopf, M; Sliwa, K; Stangl, V; Vogel-Claussen, J; Westenfeld, R1
Coats, CJ; Dalzell, JR; Jackson, AM; Jhund, PS; Petrie, MC; Walker, NL1
Bauersachs, J; Berliner, D; Hallbaum, M; Hilfiker-Kleiner, D; König, T; Kühn, C; Napp, LC; Pfeffer, TJ; Schäfer, A; Schmitto, JD; Sieweke, JT; Tongers, J1
Bauersachs, J; Hilfiker-Kleiner, D; Sliwa, K2
Arany, Z; Ersbøll, AS; Gustafsson, F1
Bauersachs, J; Berliner, D; Böhm, M; Ehlermann, P; Franke, A; Haghikia, A; Hilfiker-Kleiner, D; Kindermann, I; König, T; Kühl, U; Michels, G; Moulig, VA; Pfeffer, T; Pfister, R; Podewski, E; Schwab, J; Schwarzkopf, M; Sliwa, K; Stangl, V; Vogel-Claussen, J; Westenfeld, R; Zwadlo, C1
Fett, JD2
Afilalo, J; Avram, R; Bélisle, P; Bibas, L; Couture, E; Descarries, L; Desplantie, O; Diaz, A; Ducharme, A; Farand, P; Fortier, A; Harvey, L; Jolicoeur, EM; Ly, HQ; Malhamé, I; Marquis-Gravel, G; Pacheco, C; Poulin, A; Pranno, N; Rey, E; Sénéchal, M; Simard, F; Tournoux, F; Tran, D; Tremblay-Gravel, M1
A Kamiya, C; Eto, K; Fukui, D; Fukumoto, Y; Furusho, A; Kumanomido, J; Morikawa, N; Nakayoshi, T; Nishida, N; Nishihara, M; Watanabe, M; Yoshimura, H1
Bauersachs, J; Bovy, N; Fischer, D; Haghikia, A; Hilfiker-Kleiner, D; Jordan, J; Labidi, S; Libhaber, E; Lichtinghagen, R; Podewski, E; Roentgen, P; Sliwa, K; Struman, I; Tsikas, D; von Kaisenberg, CS1
Hamada, T; Idei, M; Sumikura, H1
Angermann, CE; Bauersachs, J; Berliner, D; Böhm, M; Fischer, D; Haghikia, A; Hilfiker-Kleiner, D; Podewski, E; Röntgen, P; Sonnenschein, K1
Avram, R; Desplantie, O; Ducharme, A; Jolicoeur, EM; Marquis-Gravel, G; Tremblay-Gravel, M1
Cardona-Guarache, R; Kron, J1
Lough, S1
Bouabdallaoui, N; Demondion, P; Ennezat, PV; Le Jemtel, TH; Lebreton, G; Mouquet, F1
Arany, Z; Elkayam, U1
Nicholls, M1
Dietz, R; Dudenhausen, JW; Elgeti, T; Habedank, D; Haverkamp, W; Kühnle, Y1
Emons, G; Hilfiker-Kleiner, D; Jahns, BG; Pieske, B; Stein, W1
Bretler, DM; Gislason, GH; Hansen, PR; Jørgensen, CH; Olesen, JB1
de Groote, P; Lamblin, N; Mouquet, F1
Biteker, M; Duran, NE; Ozkan, M1
Swalve-Bordeaux, S1
Becker, A; Blauwet, L; Hilfiker-Kleiner, D; Labidi, S; Libhaber, E; McMurray, J; Sliwa, K; Smedema, JP; Struhman, I; Struman, I; Tibazarwa, K; Yamac, H1
Elkayam, U; Goland, S1
Bultmann, I; Hilfiker-Kleiner, D; Sliwa, K; Yamac, H1
Abe, T; Akira, S; Amano, I; Nakai, A; Sawa, R; Takeshita, T1
Schröder, S; Strobel, J1
Czerski, T; Piotrowska-Kownacka, D1
Böhm, M; Friedrich, EB; Hilfiker-Kleiner, D; Kindermann, I; Labidi, S; Schirmer, SH; Schwarz, V; Sliwa, K; Solomayer, EF; Walenta, K1
Arany, Z; Bauersachs, J; Burke, SD; del Monte, F; Farrell, C; Hacker, MR; Hess, P; Hilfiker-Kleiner, D; Jang, C; Karumanchi, SA; Khankin, EV; Koulisis, N; Liu, L; Mahmood, F; Mitchell, J; Patten, IS; Rana, S; Rhee, JS; Rowe, GC; Shahul, S; Tudorache, I1
Berardini, A; Biagini, E; Graziosi, M; Pazzi, C; Rapezzi, C; Rosmini, S1
Hilfiker-Kleiner, D; Hoch, M; Podewski, E; Sliwa, K; Struman, I1
Holke, K; Schillinger, W; Schroeter, MR; Unsöld, B1
Leinwand, LA1
Ansari, A; Balligand, JL; Bonda, T; Desjardins, F; Doerries, C; Drexler, H; Forster, O; Heusch, G; Hilfiker, A; Hilfiker-Kleiner, D; Kaminski, K; Klein, G; Landmesser, U; Luchtefeld, M; Nguyen, NQ; Podewski, E; Poli, V; Quint, A; Schaefer, A; Schneider, MD; Schulz, R; Sliwa, K; Struman, I; Zschemisch, NH1
Bertoni, PD; Canziani, R; Di Michele, R; Morandi, G1
Correia, J; Hopp, L; Iffy, L; O'Donnell, J1

Reviews

9 review(s) available for bromocriptine and Cardiomyopathies, Primary

ArticleYear
Effects of bromocriptine in peripartum cardiomyopathy: a systematic review and meta-analysis.
    Heart failure reviews, 2022, Volume: 27, Issue:2

    Topics: Bromocriptine; Cardiomyopathies; Female; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Randomized Controlled Trials as Topic; Stroke Volume; Ventricular Function, Left

2022
Prolactin Inhibition in Peripartum Cardiomyopathy: Systematic Review and Meta-analysis.
    Current problems in cardiology, 2023, Volume: 48, Issue:2

    Topics: Bromocriptine; Cardiomyopathies; Female; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Stroke Volume; Ventricular Function, Left

2023
Peripartum cardiomyopathy - a cardiovascular disease in pregnancy and puerperium. The actual state of knowledge, challenges, and perspectives.
    Ginekologia polska, 2021, Volume: 92, Issue:2

    Topics: Adult; Bacterial Outer Membrane Proteins; Bromocriptine; Cardiomyopathies; Cardiotonic Agents; Female; Health Knowledge, Attitudes, Practice; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Treatment Outcome

2021
[Anesthetic management of parturients with peripartum cardiomyopathy].
    Masui. The Japanese journal of anesthesiology, 2014, Volume: 63, Issue:1

    Topics: Analgesia, Obstetrical; Anesthesia, Epidural; Anesthesia, General; Anesthesia, Obstetrical; Anesthesia, Spinal; Anesthetics, Local; Animals; Bromocriptine; Cardiomyopathies; Cesarean Section; Female; Heart Transplantation; Humans; Monitoring, Intraoperative; Mutation; Oxidative Stress; Perioperative Care; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin

2014
The Medical Treatment of New-Onset Peripartum Cardiomyopathy: A Systematic Review of Prospective Studies.
    The Canadian journal of cardiology, 2015, Volume: 31, Issue:12

    Topics: Bromocriptine; Cardiomyopathies; Echocardiography; Female; Humans; Hydrazones; Pentoxifylline; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Puerperal Disorders; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Survival Rate; Ventricular Dysfunction, Left

2015
Current knowledge and recent development on management of peripartum cardiomyopathy.
    European heart journal. Acute cardiovascular care, 2017, Volume: 6, Issue:4

    Topics: Bromocriptine; Cardiomyopathies; Echocardiography; Electrocardiography; Female; Heart Failure; Heart Transplantation; Heart-Assist Devices; Hormone Antagonists; Humans; Incidence; Natriuretic Peptide, Brain; Oxidative Stress; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Radiography, Thoracic; Ventricular Dysfunction, Left

2017
Peripartum Cardiomyopathy.
    Circulation, 2016, Apr-05, Volume: 133, Issue:14

    Topics: Bromocriptine; Cardiomyopathies; Cardiovascular Agents; Disease Susceptibility; Female; Heart Failure; Heart Transplantation; Hormones; Humans; Hypertension; Incidence; Infant, Newborn; Lactation; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy, Multiple; Puerperal Disorders

2016
Prolactin: a new therapeutic target in peripartum cardiomyopathy.
    Heart (British Cardiac Society), 2010, Volume: 96, Issue:17

    Topics: Animals; Bromocriptine; Cardiomyopathies; Disease Models, Animal; Female; Hormone Antagonists; Humans; Mice; Oxidative Stress; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders

2010
16-kDa prolactin and bromocriptine in postpartum cardiomyopathy.
    Current heart failure reports, 2012, Volume: 9, Issue:3

    Topics: Bromocriptine; Cardiomyopathies; Female; Hormone Antagonists; Humans; Oxidative Stress; Peptide Fragments; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders

2012

Trials

5 trial(s) available for bromocriptine and Cardiomyopathies, Primary

ArticleYear
Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study.
    European heart journal, 2017, Sep-14, Volume: 38, Issue:35

    Topics: Adult; Bromocriptine; Cardiomyopathies; Cardiotonic Agents; Drug Administration Schedule; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Recovery of Function; Treatment Outcome; Ventricular Dysfunction, Left

2017
Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction.
    Clinical research in cardiology : official journal of the German Cardiac Society, 2019, Volume: 108, Issue:3

    Topics: Bromocriptine; Cardiomyopathies; Dose-Response Relationship, Drug; Echocardiography; Female; Follow-Up Studies; Heart Ventricles; Hormone Antagonists; Humans; Magnetic Resonance Imaging, Cine; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Treatment Outcome; Ventricular Dysfunction, Right; Ventricular Function, Right

2019
Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy.
    Clinical research in cardiology : official journal of the German Cardiac Society, 2015, Volume: 104, Issue:11

    Topics: Adult; Bromocriptine; Cardiomyopathies; Female; Humans; Multicenter Studies as Topic; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Randomized Controlled Trials as Topic; Research Design; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left; Young Adult

2015
Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study.
    Circulation, 2010, Apr-06, Volume: 121, Issue:13

    Topics: Acute Disease; Adolescent; Adult; Blood Pressure; Bromocriptine; Cardiomyopathies; Cathepsin D; Female; Heart Failure; Hormone Antagonists; Humans; Infant, Newborn; Middle Aged; Parturition; Pilot Projects; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Prolactin; Thromboembolism; Treatment Outcome; Ultrasonography; Ventricular Function, Left; Young Adult

2010
A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy.
    Cell, 2007, Feb-09, Volume: 128, Issue:3

    Topics: Animals; Bromocriptine; Cardiomyopathies; Cathepsin D; Disease Models, Animal; Female; Heart Transplantation; Humans; Hypertrophy, Left Ventricular; Lactation; Lipoproteins, LDL; Male; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Neovascularization, Pathologic; Oxidative Stress; Peptide Fragments; Postpartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders; STAT3 Transcription Factor

2007

Other Studies

36 other study(ies) available for bromocriptine and Cardiomyopathies, Primary

ArticleYear
Review of Randomized Controlled Trials in Patients with Peripartum Cardiomyopathy.
    Current cardiology reviews, 2023, Volume: 19, Issue:2

    Topics: Bromocriptine; Cardiomyopathies; Cardiotonic Agents; Female; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Randomized Controlled Trials as Topic; Stroke Volume; Ventricular Function, Left

2023
Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy.
    ESC heart failure, 2023, Volume: 10, Issue:1

    Topics: Animals; Bromocriptine; Cabergoline; Cardiomyopathies; Dopamine Agonists; Female; Heart Failure; Mice; MicroRNAs; Myocytes, Cardiac; Peripartum Period; Pregnancy; Prolactin; Ventricular Dysfunction, Left

2023
[Peripartum Cardiomyopathy].
    Deutsche medizinische Wochenschrift (1946), 2022, Volume: 147, Issue:23

    Topics: Animals; Bromocriptine; Cardiomyopathies; Dopamine Agonists; Female; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders; Shock, Cardiogenic; Ventricular Dysfunction, Left

2022
[The Effect of Bromocriptine on Clinical and Laboratory Parameters in Patients With Peripartum Cardiomyopathy].
    Kardiologiia, 2020, Jul-07, Volume: 60, Issue:6

    Topics: Bromocriptine; Cardiomyopathies; Humans; Peripartum Period; Quality of Life; Treatment Outcome

2020
Complete recovery of fulminant peripartum cardiomyopathy on mechanical circulatory support combined with high-dose bromocriptine therapy.
    ESC heart failure, 2017, Volume: 4, Issue:4

    Topics: Acute Disease; Adult; Bromocriptine; Cardiomyopathies; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Heart-Assist Devices; Humans; Peripartum Period; Recovery of Function; Shock, Cardiogenic

2017
Bromocriptine for the treatment of peripartum cardiomyopathy: welcome on BOARD.
    European heart journal, 2017, 09-14, Volume: 38, Issue:35

    Topics: Bromocriptine; Cardiomyopathies; Female; Humans; Peripartum Period; Puerperal Disorders

2017
Peripartum cardiomyopathy: diagnosis and management.
    Heart (British Cardiac Society), 2018, Volume: 104, Issue:9

    Topics: Anticoagulants; Bromocriptine; Cardiac Resynchronization Therapy; Cardiomyopathies; Cardiotonic Agents; Contraception; Defibrillators; Delayed Diagnosis; Delivery, Obstetric; Drug Substitution; Female; Forecasting; Heart Transplantation; Heart-Assist Devices; Hormone Antagonists; Humans; Peripartum Period; Preconception Care; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Diagnosis; Puerperal Disorders; Recovery of Function; Risk Factors; Treatment Outcome

2018
Cardiogenic shock complicating peripartum cardiomyopathy: Importance of early left ventricular unloading and bromocriptine therapy.
    European heart journal. Acute cardiovascular care, 2020, Volume: 9, Issue:2

    Topics: Adult; Bromocriptine; Cardiomyopathies; Combined Modality Therapy; Extracorporeal Membrane Oxygenation; Female; Heart Failure; Hormone Antagonists; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Shock, Cardiogenic; Stroke Volume; Survival Rate; Treatment Outcome; Ventricular Function, Left

2020
Reply to 'Bromocriptine for the treatment of peripartum cardiomyopathy: comparison of outcome with a nationwide Danish cohort'.
    European heart journal, 2018, 10-01, Volume: 39, Issue:37

    Topics: Bromocriptine; Cardiomyopathies; Denmark; Female; Humans; Peripartum Period; Puerperal Disorders

2018
Bromocriptine for the treatment of peripartum cardiomyopathy: comparison of outcome with a Danish cohort.
    European heart journal, 2018, 10-01, Volume: 39, Issue:37

    Topics: Bromocriptine; Cardiomyopathies; Denmark; Female; Humans; Peripartum Period; Puerperal Disorders

2018
More study still needed on the use of bromocriptine in the treatment of peripartum cardiomyopathy.
    European heart journal, 2018, 11-14, Volume: 39, Issue:43

    Topics: Bromocriptine; Cardiomyopathies; Female; Humans; Peripartum Period; Puerperal Disorders

2018
Reply to 'More study still needed on the use of bromocriptine in the treatment of peripartum cardiomyopathy'.
    European heart journal, 2018, 11-14, Volume: 39, Issue:43

    Topics: Bromocriptine; Cardiomyopathies; Female; Humans; Peripartum Period; Puerperal Disorders

2018
The effect of bromocriptine on left ventricular functional recovery in peripartum cardiomyopathy: insights from the BRO-HF retrospective cohort study.
    ESC heart failure, 2019, Volume: 6, Issue:1

    Topics: Adult; Bromocriptine; Cardiomyopathies; Dopamine Agonists; Echocardiography; Female; Follow-Up Studies; Heart Ventricles; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Recovery of Function; Retrospective Studies; Stroke Volume; Treatment Outcome; Ventricular Function, Left

2019
The Use of Bromocriptine for Peripartum Cardiomyopathy after Twin Delivery via Oocyte Donation.
    Internal medicine (Tokyo, Japan), 2019, Feb-15, Volume: 58, Issue:4

    Topics: Bromocriptine; Cardiomyopathies; Female; Humans; Middle Aged; Oocyte Donation; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left

2019
Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy.
    Basic research in cardiology, 2013, Volume: 108, Issue:4

    Topics: Adult; Antihypertensive Agents; Bromocriptine; Cardiomyopathies; Cohort Studies; Disease Management; Drug Therapy, Combination; Female; Follow-Up Studies; Germany; Humans; Oxidative Stress; Peripartum Period; Phenotype; Pregnancy; Prospective Studies; Registries; Stroke Volume; Treatment Outcome

2013
Treatment of Peripartum Cardiomyopathy: A Call to Action.
    The Canadian journal of cardiology, 2015, Volume: 31, Issue:12

    Topics: Bromocriptine; Cardiomyopathies; Female; Humans; Hydrazones; Pentoxifylline; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Pyridazines

2015
Resident-initiated research bucks tradition.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2015, Aug-11, Volume: 187, Issue:11

    Topics: Biomedical Research; Bromocriptine; Canada; Cardiology; Cardiomyopathies; Financial Management; Humans; Internship and Residency; Needs Assessment; Pilot Projects; Research Support as Topic

2015
An airport meeting that led to bromocriptine use in peripartum cardiomyopathy.
    European heart journal, 2016, 11-21, Volume: 37, Issue:44

    Topics: Airports; Animals; Bromocriptine; Cardiomyopathies; Female; Humans; Mice; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders

2016
Recovery from peripartum cardiomyopathy after treatment with bromocriptine.
    European journal of heart failure, 2008, Volume: 10, Issue:11

    Topics: Adult; Bromocriptine; Cardiomyopathies; Female; Follow-Up Studies; Heart Failure; Hormone Antagonists; Humans; Infant, Newborn; Magnetic Resonance Imaging; Male; Postpartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Recovery of Function

2008
Peripartum cardiomyopathy--a new treatment option by inhibition of prolactin secretion.
    American journal of obstetrics and gynecology, 2008, Volume: 199, Issue:4

    Topics: Adult; Bromocriptine; Cardiomyopathies; Cathepsin D; Female; Heart Failure; HELLP Syndrome; Hormone Antagonists; Humans; Myocardium; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin

2008
[Peripartum cardiomyopathy].
    Ugeskrift for laeger, 2009, Jan-05, Volume: 171, Issue:1-2

    Topics: Bromocriptine; Cardiomyopathies; Female; Hormone Antagonists; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Risk Factors

2009
Indication for bromocriptine in peripartum cardiomyopathy.
    European journal of heart failure, 2009, Volume: 11, Issue:2

    Topics: Bromocriptine; Cardiomyopathies; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular

2009
The role of bromocriptine in peripartum cardiomyopathy.
    American journal of obstetrics and gynecology, 2009, Volume: 201, Issue:2

    Topics: Bromocriptine; Cardiomyopathies; Female; Hormone Antagonists; Humans; Pregnancy; Pregnancy Complications, Cardiovascular

2009
Correspondence (letter to the editor): Case numbers are tiny.
    Deutsches Arzteblatt international, 2009, Volume: 106, Issue:11

    Topics: Bromocriptine; Cardiomyopathies; Female; Hormone Antagonists; Humans; Pregnancy; Pregnancy Complications, Cardiovascular

2009
Bromocriptine for the treatment of peripartum cardiomyopathy.
    Circulation, 2010, Apr-06, Volume: 121, Issue:13

    Topics: Bromocriptine; Cardiomyopathies; Female; Hormone Antagonists; Humans; Pregnancy; Pregnancy Complications, Cardiovascular

2010
Recovery from peripartum cardiomyopathy in a Japanese woman after administration of bromocriptine as a new treatment option.
    Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2010, Volume: 77, Issue:4

    Topics: Asian People; Bromocriptine; Cardiomyopathies; Dopamine Agonists; Female; Humans; Natriuretic Peptide, Brain; Pleural Effusion; Pregnancy; Pregnancy Complications, Cardiovascular; Pulmonary Edema; Radiography, Thoracic; Time Factors; Ultrasonography

2010
[Postpartum cardiomyopathy].
    Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:22

    Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Antihypertensive Agents; Bisoprolol; Bromocriptine; Cardiomyopathies; Female; Heparin, Low-Molecular-Weight; Humans; Mineralocorticoid Receptor Antagonists; Postpartum Period; Radiography; Ramipril; Risk Factors; Spironolactone; Sulfonamides; Torsemide; Treatment Outcome

2011
[Pulmonary oedema--as first symptom of the postpartum cardiomyopathy. The role of cardiac MRI in diagnostic process].
    Kardiologia polska, 2011, Volume: 69, Issue:9

    Topics: Bromocriptine; Cardiomyopathies; Cesarean Section; Diagnosis, Differential; Eclampsia; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Postpartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Pulmonary Edema; Radiography; Young Adult

2011
Circulating microparticles as indicators of peripartum cardiomyopathy.
    European heart journal, 2012, Volume: 33, Issue:12

    Topics: Adult; Analysis of Variance; Biomarkers; Bromocriptine; Cardiomyopathies; Case-Control Studies; Cell-Derived Microparticles; Female; Flow Cytometry; Hormone Antagonists; Humans; Pregnancy; Puerperal Disorders

2012
Cardiac angiogenic imbalance leads to peripartum cardiomyopathy.
    Nature, 2012, May-09, Volume: 485, Issue:7398

    Topics: Animals; Bromocriptine; Cardiomyopathies; Disease Models, Animal; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Mice; Mice, Knockout; Myocytes, Cardiac; Neovascularization, Pathologic; Neovascularization, Physiologic; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Trans-Activators; Transcription Factors; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1

2012
[Gender effect on cardiomyopathy].
    Giornale italiano di cardiologia (2006), 2012, Volume: 13, Issue:6

    Topics: Bromocriptine; Cabergoline; Cardiomyopathies; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Cardiomyopathy, Restrictive; Dopamine Agonists; Ergolines; Evidence-Based Medicine; Female; Genetic Counseling; Humans; Phenotype; Pregnancy; Pregnancy Complications, Cardiovascular; Prognosis; Prolactin; Risk Assessment; Risk Factors; Sex Factors; Treatment Outcome

2012
Pro-thrombotic condition in a woman with peripartum cardiomyopathy treated with bromocriptine and an Impella LP 2.5 heart pump.
    Clinical research in cardiology : official journal of the German Cardiac Society, 2013, Volume: 102, Issue:2

    Topics: Adult; Anticoagulants; Blood Coagulation Tests; Bromocriptine; Cardiomyopathies; Dopamine Agonists; Echocardiography, Doppler, Color; Echocardiography, Transesophageal; Female; Heart-Assist Devices; Humans; Peripartum Period; Pregnancy; Puerperal Disorders; Thrombosis; Treatment Outcome; Ventricular Function, Left

2013
Molecular events underlying pregnancy-induced cardiomyopathy.
    Cell, 2007, Feb-09, Volume: 128, Issue:3

    Topics: Animals; Bromocriptine; Cardiomyopathies; Cathepsin D; Disease Models, Animal; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders; STAT3 Transcription Factor

2007
Caution in the use of bromocriptine in peripartum cardiomyopathy.
    Journal of the American College of Cardiology, 2008, May-27, Volume: 51, Issue:21

    Topics: Bromocriptine; Cardiomyopathies; Developing Countries; Female; Heart Failure; Hormone Antagonists; Humans; Prolactin; Puerperal Disorders

2008
[Acromegalic cardiomyopathy: an echocardiographic study].
    Giornale italiano di cardiologia, 1983, Volume: 13, Issue:3

    Topics: Acromegaly; Adult; Aged; Bromocriptine; Cardiomyopathies; Echocardiography; Electrocardiography; Female; Humans; Hypophysectomy; Male; Middle Aged

1983
Severe cardiac dysrhythmia in patients using bromocriptine postpartum.
    American journal of therapeutics, 1998, Volume: 5, Issue:2

    Topics: Adult; Arrhythmias, Cardiac; Bromocriptine; Cardiomyopathies; Causality; Dopamine Agonists; Electrocardiography; Fatal Outcome; Female; Humans; Hypertension; Lactation; Long QT Syndrome; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders

1998